BioCryst Pharmaceuticals, Inc. (BCRX)
8.48
-0.02
(-0.24%)
USD |
NASDAQ |
Mar 06, 16:00
8.48
0.00 (0.00%)
After-Hours: 20:00
BioCryst Pharmaceuticals Total Liabilities (Quarterly) : 633.31M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 58.97M |
| Lantheus Holdings, Inc. | 1.138B |
| Plus Therapeutics, Inc. | 13.62M |
| BioStem Technologies, Inc. | 12.38M |
| Iovance Biotherapeutics, Inc. | 214.59M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 514.16M |
| Shareholders Equity (Quarterly) | -119.15M |
| Debt to Equity Ratio | -4.006 |
| Current Ratio | 2.062 |
| Net Debt Paydown Yield | 4.39% |